VANGUARD GROUP INC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$9,480,217
-57.7%
3,108,268
+24.7%
0.00%
Q1 2024$22,385,792
-56.2%
2,492,850
+21.2%
0.00%
-100.0%
Q4 2023$51,097,091
+52.0%
2,056,221
+1.6%
0.00%0.0%
Q3 2023$33,627,330
-7.6%
2,023,305
+3.9%
0.00%0.0%
Q2 2023$36,407,947
+25.5%
1,946,949
+23.1%
0.00%0.0%
Q1 2023$29,020,856
-2.8%
1,581,518
+4.9%
0.00%0.0%
Q4 2022$29,842,026
-3.4%
1,507,173
+17.4%
0.00%0.0%
Q3 2022$30,891,000
+33.8%
1,283,908
+1.5%
0.00%0.0%
Q2 2022$23,096,000
-14.2%
1,265,545
+3.3%
0.00%0.0%
Q1 2022$26,928,000
-39.2%
1,224,545
+1.5%
0.00%0.0%
Q4 2021$44,309,000
+32.3%
1,206,352
+11.8%
0.00%0.0%
Q3 2021$33,499,000
+15.3%
1,078,886
+18.1%
0.00%0.0%
Q2 2021$29,054,000
+74.2%
913,916
+21.6%
0.00%
Q1 2021$16,681,000
+15.2%
751,400
+2.5%
0.00%
Q4 2020$14,480,000
-23.1%
733,193
+25.3%
0.00%
-100.0%
Q3 2020$18,838,000
+42.0%
585,021
+28.0%
0.00%
Q2 2020$13,266,000
+122.5%
457,157
+63.1%
0.00%
Q1 2020$5,961,000
+50.2%
280,270
+95.0%
0.00%
Q4 2019$3,968,000143,7230.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$49,662,00044.09%
KPCB XV Associates, LLC 1,297,063$40,274,00030.08%
Euclidean Capital LLC 635,177$19,722,0009.59%
Ponoi II Management, LLC 145,401$4,515,0006.69%
Column Group LLC 1,402,008$43,532,0004.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,148,321$35,655,0004.34%
Trustees of Columbia University in the City of New York 73,383$2,279,0003.48%
Ghost Tree Capital, LLC 250,000$7,763,0002.27%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 608,663$18,899,0002.22%
AJU IB Investment Co., Ltd. 99,503$3,090,0001.99%
View complete list of RAPT THERAPEUTICS INC shareholders